Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept.

Slides:

Advertisements

Similar presentations

The TEAD/TEF Family of Transcription Factor Scalloped Mediates Hippo Signaling in Organ Size Control Lei Zhang, Fangfang Ren, Qing Zhang, Yongbin Chen,

Advertisements

Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome Dapeng Jin, MS, Shaoping Wu, PhD, Yong-guo Zhang,

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Volume 387, Issue 10037, Pages (June 2016)

Volume 388, Issue 10058, Pages (November 2016)

Volume 379, Issue 9824, Pages (April 2012)

Volume 357, Issue 9262, Pages (April 2001)

Pharmacogenetics and future drug development and delivery

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg- positive chronic hepatitis B virus infection: a randomised, double-blind,

Volume 385, Issue 9984, Pages (June 2015)

Volume 124, Issue 3, Pages (September 2003)

Status of clinical research in China

Volume 382, Issue 9887, Pages (July 2013)

A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection

Volume 389, Issue 10069, Pages (February 2017)

Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled.

Chronic Hepatitis C Therapy: Changing the Rules of Duration

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg- positive chronic hepatitis B virus infection: a randomised, double-blind,

Optimum timing of treatment for hepatitis C infection relative to liver transplantation Dr Audrey Coilly, MD, Bruno Roche, MD, Prof Jean-Charles Duclos-Vallée,

Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China:

Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis Christian Løvold Storhaug, MS, Svein.

Multiple skin ulcers from malignant syphilis

Covering the Cover Gastroenterology

Changing cancer survival in China during 2003–15: a pooled analysis of 17 population- based cancer registries Hongmei Zeng, PhD, Prof Wanqing Chen, MD,

A Model to Determine 3-Month Mortality Risk in Patients With Acute-on-Chronic Hepatitis B Liver Failure Ming–Hua Zheng, Ke–Qing Shi, Yu–Chen Fan, Hai.

Volume 74, Issue 6, Pages (December 2018)

Volume 379, Issue 9816, Pages (February 2012)

Travel-related infections in mainland China, 2014–16: an active surveillance study Prof Li-Qun Fang, PhD, Yu Sun, PhD, Guo-Ping Zhao, MS, Prof Li-Juan.

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Volume 381, Issue 9882, Pages (June 2013)

Gene therapy—where are we?

Volume 2, Issue 12, Pages (December 2015)

Volume 372, Issue 9642, Pages (September 2008)

Multiple skin ulcers from malignant syphilis

Yasuhiko Sugawara, Masatoshi Makuuchi

Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised,

Early Virologic Responses and Hematologic Safety of Direct-Acting Antiviral Therapies in Veterans With Chronic Hepatitis C Pamela S. Belperio, Elizabeth.

HIV myths should not be resuscitated

Volume 375, Issue 9732, Pages (June 2010)

Challenges to eliminate rabies virus infection in China by 2020

Resuscitation at birth and cognition at 8 years of age: a cohort study

Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study Jue Liu, PhD, Shikun Zhang, MD,

Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay? Brian J. McMahon, MD, Brenna C. Simons, PhD Clinical.

Surrogate End Points and Long-Term Outcome in Patients With Chronic Hepatitis B Vincent Wai–Sun Wong, Grace Lai–Hung Wong, Angel Mei–Ling Chim, Paul Cheung–Lung.

The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China Yue Li, Li-fan Zhang, Xiao-qing.

Volume 362, Pages s6-s7 (December 2003)

Volume 385, Issue 9984, Pages (June 2015)

Volume 393, Issue 10171, Pages (February 2019)

Confessions of a journal junkie

MA17.05 Evolutionary Trajectories of Molecular Progression in Different Subtypes of Primary Lung Adenocarcinomas Hao-Ran Zhai, Shiyong Li, Bing Liao,

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised,

New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis Pengcheng Ou, MD, Fangfang.

National incidence of traumatic fractures in China: a retrospective survey of 512 187 individuals Wei Chen, MD, Hongzhi Lv, MD, Song Liu, MD, Bo Liu,

Telling it like it isn't: truth and lies in a post-9/11 world

Chronic Hepatitis C Therapy: Changing the Rules of Duration

Jin-Hee Park, RN, Ph. D. , Mison Chun, M. D. , Ph. D

Application of three-dimensional fluorescence in situ hybridization to human preimplantation genetic diagnosis Li-Ying Yan, Ph.D., Jie Qiao, M.D., Yuan.

Efficacy and safety of tribendimidine against Opisthorchis viverrini: two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials Somphou.

Alan Bonder, MD, Nezam H. Afdhal, MD

Jiayue Hu, George Fu Gao, Ji-Long Chen The Lancet

Volume 1, Issue 1, Pages (June 2014)

Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup:

Issue Highlights Clinical Gastroenterology and Hepatology

Scott K. Fung, Anna S.F. Lok Clinical Gastroenterology and Hepatology

Volume 383, Issue 9930, Pages (May 2014)

Volume 382, Issue 9887, Pages (July 2013)

Volume 65, Issue 4, Pages (October 2016)

Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,

The dilemma of vaginal breech delivery worldwide

Chat-based instant messaging support integrated with brief interventions for smoking cessation: a community-based, pragmatic, cluster-randomised controlled.

Presentation transcript:

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study Prof George Lau, MD, Yves Benhamou, MD, Prof Guofeng Chen, MD, Prof Jin Li, MD, Prof Qing Shao, MD, Dong Ji, MD, Fan Li, MD, Bing Li, MD, Jialiang Liu, MD, Prof Jinlin Hou, MD, Prof Jian Sun, MD, Cheng Wang, MD, Jing Chen, PhD, Vanessa Wu, BSc, April Wong, BSc, Chris L P Wong, PhD, Stella T Y Tsang, PhD, Yudong Wang, PhD, Leda Bassit, PhD, Sijia Tao, PhD, Yong Jiang, PhD, Hui- Mien Hsiao, MS, Ruian Ke, PhD, Alan S Perelson, PhD, Prof Raymond F Schinazi, PhD The Lancet Gastroenterology & Hepatology Volume 1, Issue 2, Pages 97-104 (October 2016) DOI: 10.1016/S2468-1253(16)30015-2 Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile uRVR=ultrarapid virological response. The Lancet Gastroenterology & Hepatology 2016 1, 97-104DOI: (10.1016/S2468-1253(16)30015-2) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 2 Decline in mean hepatitis C viral load Solid lines are mean model trajectories calculated from predicted viral load (see appendix p 9). Dashed horizontal line indicates the assay lower limit of quantification. The Lancet Gastroenterology & Hepatology 2016 1, 97-104DOI: (10.1016/S2468-1253(16)30015-2) Copyright © 2016 Elsevier Ltd Terms and Conditions